Biofreeze

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with conditions such as simple backache, arthritis, strains, bruises, and sprains.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are instructed to apply the spray to the affected areas, with a maximum frequency of four times daily. It is not necessary to massage the area after application. For children under 12 years of age, consultation with a physician is recommended prior to use.

After application, it is essential to wash hands thoroughly with cool water to prevent any unintended contact with other areas of the body or surfaces.

Contraindications

The product is contraindicated for use in the following situations:

Application to wounds or damaged skin is prohibited due to the potential for adverse effects. It should not be applied to irritated skin or in cases where excessive irritation develops, as this may exacerbate the condition. Additionally, tight bandaging or the use of heating pads or devices in conjunction with the product is contraindicated, as this may lead to increased risk of irritation or other complications. Contact with the eyes or mucous membranes must be avoided to prevent irritation or injury.

Warnings and Precautions

For external use only. This product is flammable; therefore, it must be kept away from excessive heat or open flame. The contents are under pressure; puncturing or incinerating the container is strictly prohibited. Additionally, it should not be stored at temperatures exceeding 120°F.

Healthcare professionals should advise patients to consult a doctor prior to use if they experience any of the following: pain, swelling, or blistering of the skin; worsening of the condition; symptoms persisting for more than 7 days; or if symptoms clear up and then recur within a few days. Furthermore, if arthritic pain persists for more than 10 days or if redness is present, medical consultation is recommended.

When using this product, it is imperative to follow the directions provided. Users should avoid contact with the eyes and mucous membranes, and the product should not be applied to wounds, damaged skin, or irritated skin. If excessive irritation develops, use should be discontinued. Additionally, the product should not be bandaged tightly or used in conjunction with a heating pad or device.

Patients should be instructed to stop use and seek medical advice if the condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Side Effects

Patients using this product may experience various adverse reactions. Serious reactions may include pain, swelling, or blistering of the skin. Participants should seek medical advice if these symptoms occur, or if the condition worsens. Additionally, if symptoms persist for more than 7 days, or if they clear up and recur within a few days, it is recommended to consult a healthcare professional.

Common adverse reactions may involve arthritic pain that persists for more than 10 days, particularly if accompanied by redness. Patients are advised to stop use and consult a doctor under these circumstances.

While using this product, it is crucial to avoid contact with the eyes and mucous membranes. The product should not be applied to wounds, damaged skin, or irritated areas. If excessive irritation develops, discontinuation of use is advised. Furthermore, patients should refrain from tightly bandaging the area or using heating pads or devices in conjunction with the product.

This product is for external use only and is flammable; therefore, it should be kept away from excessive heat or open flames. The contents are under pressure, and users should not puncture or incinerate the container. It is also important to store the product at temperatures not exceeding 120°F. In the event of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center is recommended.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Biofreeze (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 12 years and older may use the product by spraying it onto the affected areas up to four times daily, with no need for massage. For children under 12 years of age, it is recommended to consult a physician prior to use.

Geriatric Use

There is no specific information regarding the use of Biofreeze Professional menthol spray in geriatric patients. The prescribing information does not indicate any dosage adjustments, safety concerns, or special precautions that are specifically applicable to elderly patients. Healthcare providers should exercise clinical judgment when considering the use of this product in geriatric populations, as individual patient factors may necessitate careful monitoring and assessment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully known. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate management and consideration of any potential risks.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, it is imperative that immediate medical assistance is sought. Healthcare professionals should advise patients or caregivers to contact a Poison Control Center without delay if the substance is accidentally ingested.

Prompt intervention is crucial to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by medical personnel is essential.

Management procedures will typically involve supportive care and symptomatic treatment, tailored to the individual case. Continuous monitoring of the patient’s condition is recommended to address any complications that may arise during the course of treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and respiratory issues. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the product is accidentally ingested. It is essential to instruct patients to use the product only as directed to ensure safety and efficacy.

Patients should be cautioned to avoid contact with the eyes and mucous membranes, as this may lead to irritation. Additionally, they should not apply the product to wounds or damaged skin, nor should it be used on irritated skin or if excessive irritation develops.

Healthcare providers should emphasize that patients should not bandage the area tightly or use the product in conjunction with a heating pad or device, as this may increase the risk of adverse effects.

Patients should be informed to discontinue use and consult a doctor if their condition worsens, if symptoms persist for more than 7 days, or if symptoms clear up and then recur. It is also important for patients to seek medical advice before using the product if they experience pain, swelling, or blistering of the skin.

Furthermore, patients should be encouraged to consult a healthcare professional if their condition worsens, if symptoms persist beyond 7 days, or if symptoms clear up and reappear within a few days. For those experiencing arthritic pain that lasts more than 10 days or if redness is present, it is crucial to seek medical advice before continuing use.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at a temperature range of 20-25°C (68-77°F).

For optimal preservation, the product should be kept in a cool, dry place, ensuring it is protected from direct sunlight. Proper storage conditions are crucial to maintain the integrity and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Biofreeze, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)